Healthcare staffing company AMN Healthcare Services (NYSE: AMN) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $673.2 million. On top of that, next quarter’s revenue guidance ($647.5 million at the midpoint) was surprisingly good and 4.7% above what analysts were expecting. Its non-GAAP profit of $0.77 per share was significantly above analysts’ consensus estimates.

Is now the time to buy AMN Healthcare Services? Find out by accessing our full research report, it’s free.

Company Overview

With a network of thousands of healthcare professionals ranging from nurses to physicians to executives, AMN Healthcare (NYSE: AMN) provides healthcare workforce solutions including temporary staffing, permanent placement, and technology platforms for hospitals and healthcare facilities across the United States.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Regrettably, AMN Healthcare Services’s sales grew at a tepid 3.3% compounded annual growth rate over the last five years. This fell short of our benchmark for the healthcare sector and is a tough starting point for our analysis.

Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. AMN Healthcare Services’s annualized revenue growth of 3.1% over the last two years aligns with its five-year trend, suggesting its demand was consistently weak.

AMN Healthcare Services also reports its number of travelers on assignment, which reached 9,194 in the latest quarter. Over the last two years, AMN Healthcare Services’s travelers on assignment averaged 8.6% year-on-year declines. Because this number is lower than its revenue growth, we can see the company benefited from price increases.

This quarter, AMN Healthcare Services reported modest year-on-year revenue growth of 2.3% but beat Wall Street’s estimates by 7.2%. Company management is currently guiding for a 2% year-on-year increase in sales next quarter.

Looking further ahead, sell-side analysts expect revenue to decline by 25.9% over the next 12 months, a deceleration versus the last two years. This projection doesn’t excite us and suggests its products and services will see some demand headwinds.

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

Adjusted Operating Margin

AMN Healthcare Services was profitable over the last five years but held back by its large cost base. Its average adjusted operating margin of 8.4% was weak for a healthcare business.

Looking at the trend in its profitability, AMN Healthcare Services’s adjusted operating margin decreased by 7.4 percentage points over the last five years. The company’s two-year trajectory also shows it failed to get its profitability back to the peak as its margin fell by 1.3 percentage points. This performance was poor no matter how you look at it - it shows its expenses were rising and it couldn’t pass those costs onto its customers.

This quarter, AMN Healthcare Services generated an adjusted operating margin profit margin of 4%, up 22 percentage points year on year. This increase was a welcome development and shows it was more efficient.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth — for example, a company could inflate its sales through excessive spending on advertising and promotions.

Sadly for AMN Healthcare Services, its EPS declined by 7.6% annually over the last five years while its revenue grew by 3.3%. This tells us the company became less profitable on a per-share basis as it expanded due to non-fundamental factors such as interest expenses and taxes.

Diving into the nuances of AMN Healthcare Services’s earnings can give us a better understanding of its performance. As we mentioned earlier, AMN Healthcare Services’s adjusted operating margin expanded this quarter but declined by 7.4 percentage points over the last five years. This was the most relevant factor (aside from the revenue impact) behind its lower earnings; interest expenses and taxes can also affect EPS but don’t tell us as much about a company’s fundamentals.

In Q2, AMN Healthcare Services reported adjusted EPS of $0.77, up from $0.30 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects AMN Healthcare Services’s full-year EPS to shrink by 74.7% from $3.48 to $0.88.

Key Takeaways from AMN Healthcare Services’s Q2 Results

It was good to see AMN Healthcare Services beat analysts’ EPS expectations this quarter. We were also excited its revenue outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 11.5% to $34.29 immediately following the results.

Indeed, AMN Healthcare Services had a rock-solid quarterly earnings result, but is this stock a good investment here? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).